Author

Hiromi Ii

Kyoto Pharmaceutical UniversityORCID 0000-0003-1152-7767Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Kosei ItoiD· 1 shared Shohei Otani· 1 shared Susumu KageyamaiD· 1 shared Susumu NakataiD· 1 shared Tomoko ItoiD· 1 shared Tomoya UenoiD· 1 shared Yu Katsuma· 1 shared Yuki DateiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Kosei ItoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer SciencePeer-reviewedJun 26, 2024

Myc upregulates Ggct, γ-glutamylcyclotransferase to promote development of p53-deficient osteosarcoma

Tomoya Ueno, Shohei Otani, Yuki Date…·Kosei Ito

The paper identifies GGCT as a Myc-target gene that promotes p53-deficient osteosarcoma development and suggests it as a potential therapeutic target.

6 citations

humanmouse

𝕏 PostBluesky